Mergers and acquisitions grabbed the spotlight in the biotech sector once again this week after BioMarin BMRN agreed to ...

J&J’s JNJ stock has declined 6.4% in the past three months. J&J faces several challenges, including slowing sales in the ...

Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...

Pfizer will pay China’s 3SBio $1.25 billion up front to access a cancer drug that could rival Akeso and Summit’s closely ...

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...

The NFL has put its coaching accelerator program designed to bolster diversity efforts on hold. It makes the NFL look weak ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Gilead Sciences, Inc. (NASDAQ:GILD)  plans to present over 20 research abstracts—spanning both Gilead and its cell therapy ...

The University of Minnesota Medical School and Fairview are expanding rural physician training in the state with a new residency program. The Grand Itasca Clinic & Hospital Rural Family Medicine ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

An Iowa Utilities Commission member and two human and civil rights panel appointees were among the governor's appointees the Senate has confirmed.